Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines

Author： Berzi Angela Varga Norbert Sattin Sara Antonazzo Patrizio Biasin Mara Cetin Irene Trabattoni Daria Bernardi Anna Clerici Mario

Publisher： MDPI

E-ISSN： 1999-4915|6|2|391-403

ISSN： 1999-4915

Source： Viruses, Vol.6, Iss.2, 2014-01, pp. : 391-403

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines

By Savelkoul Huub F. J. Ferro Valerie A. Strioga Marius M. Schijns Virgil E. J. C.

Vaccines, Vol. 3, Iss. 1, 2015-03 ,pp. : 148-171

MDPI

Access to resources Recommend Favorite

The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration

By Harmon Thomas Guo Wei Stover John Wu Zunyou Kaufman Joan Schneider Kammerle Liu Li Feng Liao Schwartländer Bernard

Vaccines, Vol. 3, Iss. 1, 2015-01 ,pp. : 1-19

MDPI

Access to resources Recommend Favorite

The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States

By Adamson Blythe J. S. Carlson Josh J. Kublin James G. Garrison Louis P.

Vaccines, Vol. 5, Iss. 2, 2017-05 ,pp. : 13-13

MDPI

Access to resources Recommend Favorite

Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators

By Tandrup Schmidt Signe Foged Camilla Smith Korsholm Karen Rades Thomas Christensen Dennis

Pharmaceutics, Vol. 8, Iss. 1, 2016-03 ,pp. : 7-7

MDPI

Access to resources Recommend Favorite

Virus-Like-Vaccines against HIV

By Andersson Anne-Marie C. Schwerdtfeger Melanie Holst Peter J.

Vaccines, Vol. 6, Iss. 1, 2018-02 ,pp. : 10-10

MDPI

Access to resources Recommend Favorite